Main Article Content
The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.
What are my rights as author?
It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as
Author. Journal's standard policies allow the following re-use rights:
- The journal allow the author(s) to hold the copyright without restrictions.
- The journal allow the author(s) to obtain publishing rights without restrictions.
- You may do whatever you wish with the version of the article you submitted to the journal.
- Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.
- You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.
- You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.
2. Gururaj G, Girish N, Isaac MK. NCMH Background Papers-Burden of disease in India. New Delhi: Ministry of Health & Family Welfare. 2005
3. Markopoulos AK. Current aspects on oral squamous cell carcinoma. The open dentistry journal. 2012; 6:126.
4. Gupta S, Singh R, Gupta OP, Tripathi A. Prevalence of oral cancer and pre-cancerous lesions and the association with numerous risk factors in North India: A hospital based study. National Journal of Maxillofacial Surgery. 2014;5(2):142-148.
5. Katakwar P, Metgud R, Naik S, Mittal R. Oxidative stress marker in oral cancer: a review. Journal of cancer research and therapeutics. 2016;12(2):438.
6. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol.Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;321(17):1196-7.
7. Aksoy-Sagirli P, Cakmakoglu B, Isbir T, Kaytan-Saglam E, Kizir A, Topuz E, Berkkan H. Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population. Anticancer research. 2011; 31(6):2225-9.
8. Metin ZB, Aydin S, Unur M, Cakmakoglu B, Toptas B, Hafiz G, Ä°sbir T. Oral squamous cell carcinoma and serum paraoxonase 1. The Journal of Laryngology & Otology. 2013; 127(12):1208-13.
9. Gan KN, Smolen AN, Eckerson HW, La Du BN. Purification of human serum paraoxonase/ arylesterase. Evidence for one esterase catalyzing both activities. Drug Metabolism and Disposition. 1991;19(1):100-6
10. Buege JA, Aust SD. The thiobarbituric acid assay Metods Enzymmol 1978; 52:306-7.
11. Kyaw A. A simple colorimetric method for ascorbic acid determination in blood plasma. Clinica chimica acta. 1978 Jun 1; 86(2):153-7
12. Ghom AG, Ghom SA. Textbook of oral medicine. JP Medical Ltd; 2014 Sep 30,Chapter 12,Page 221
13. Warnakulasuriya S, Johnson N, Van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. Journal of oral pathology & medicine. 2007; 36(10):575-80.
14. Yardimci G, Kutlubay Z, Engin B, Tuzun Y. Precancerous lesions of oral mucosa.
World Journal of Clinical Casesâ€¯: WJCC. 2014;2(12):866-872.
15. Murti PR, Bhonsle RB, Pindborg JJ, Daftary DK, Gupta PC, Mehta FS. Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol. 1985;13(6):340-1.
16. Petti S. Pooled estimate of world leukoplakia prevalence: A systemic review. Oral
17. Mehta FS, Gupta PC, Daftary DK, Pindborg JJ, Choksi SK. An epidemiological study of oral cancer and precancerous condition among 101,761 villagers in Maharashtra, India. Int J Cancer. 1972;10:134â€“41.
18. Pindborg JJ, Chawla TN, Mishra RK, Nagpaul RK, Gupta VK. Frequency of oral carcinoma, leukoplakia, leukokeratosis, leukoedema, sub mucous fibrosis and lichen planus in 10,000 Indians in Lucknow, Uttar Pradesh India; Preliminary Report. J Dent Res. 1965;44:61.
19. Saran S, Agrawal GN. Cancer pattern in central U.P. Indian J Cancer. 1984;21(5):133-6.
20. Mackness B, Hunt R, Durrington PN, Mackness MI. Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein AI in the human artery wall with the progression of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology. d1997; 17(7):1233-8.
21. Mouhamed DH, Ezzaher A, Mechri A, Neffati F, Omezzine A, Bouslama A, Gaha L, Douki W, Najjar MF. Effect of cigarette smoking on paraoxonase 1 activity according to PON1 L55M and PON1 Q192R gene polymorphisms. Environmental health and preventive medicine. 2012; 17(4):316-21
22. Chole RH, Patil RN, Basak A, Palandurkar K, Bhowate R. Estimation of serum malondialdehyde in oral cancer and precancer and its association with healthy individuals, gender, alcohol, and tobacco abuse. Journal of cancer research and therapeutics. 2010 Oct 1; 6(4):487.
23. Gupta S, Reddy MV, Harinath BC. Role of oxidative stress and antioxidants in aetiopathogenesis and management of oral submucous fibrosis. Indian journal of Clinical biochemistry. 2004 Jan 1; 19(1):138.
24. Metgud R, Bajaj S. Evaluation of salivary and serum lipid peroxidation, and glutathione in oral leukoplakia and oral squamous cell carcinoma. Journal of oral science. 2014; 56(2):135-42.
25. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A. 1989; 86(16):6377-81.
26. Basu S. Antioxidant Changes in Precancerous and Cancerous Lesions of Oral Cavity.
International Journal of Life Sciences Research. 2015; 3(1):23-28.
27. Tuovinen V, VÃ¤Ã¤nÃ¤nen M, Kullaa A, KarinpÃ¤Ã¤ A, Markkanen H, Kumpusalo E. Oral mucosal changes related to plasma ascorbic acid levels. Proc Finn Dent Soc.1992;88(3-4):117-22.
28. Rajendran R. Oral submucous fibrosis: etiology, pathogenesis, and future research.
Bulletin of the World Health Organization. 1994;72(6):985.